Skip to main content

Table 4 Respondents’ scores on importance of specific elements in information brought by pharmaceutical sales representatives (scale: 1–10; n = 200)

From: Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy

 

Average score

% scoring at least 8/10

Availability of RCTs vs placebo

8.1

81 %

Use of absolute risk differences

8.0

79 %

Availability of RCTs vs best alternative treatment

8.0

77 %

Detailed information about patient characteristics

8.0

76 %

Availability of systematic reviews

7.9

75 %

Availability of RCTs not sponsored by drug companies

7.9

74 %

Indication of the added value of drugs under study

7.9

71 %